These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9840184

  • 21. UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner.
    Haapajärvi T, Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang XF, Laiho M.
    Exp Cell Res; 1999 Apr 10; 248(1):272-9. PubMed ID: 10094833
    [Abstract] [Full Text] [Related]

  • 22. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR.
    Nutr Cancer; 1999 Apr 10; 33(2):165-73. PubMed ID: 10368812
    [Abstract] [Full Text] [Related]

  • 23. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
    Cordes N, Plasswilm L, Bamberg M, Rodemann HP.
    Int J Radiat Biol; 2002 Jan 10; 78(1):17-27. PubMed ID: 11747550
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses.
    Kohli M, Jorgensen TJ.
    Biochem Biophys Res Commun; 1999 Apr 02; 257(1):168-76. PubMed ID: 10092528
    [Abstract] [Full Text] [Related]

  • 26. p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites.
    Stivala LA, Riva F, Cazzalini O, Savio M, Prosperi E.
    Oncogene; 2001 Feb 01; 20(5):563-70. PubMed ID: 11313988
    [Abstract] [Full Text] [Related]

  • 27. Telomerase-immortalized human fibroblasts retain UV-induced mutagenesis and p53-mediated DNA damage responses.
    Porter PC, Clark DR, McDaniel LD, McGregor WG, States JC.
    DNA Repair (Amst); 2006 Jan 05; 5(1):61-70. PubMed ID: 16140041
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Loss of TP53-DNA interaction induced by p.C135R in lung cancer.
    Aranda M, Gonzalez-Nilo F, Riadi G, Díaz V, Perez J, Martel G, Hainaut P, Mimbacas A.
    Oncol Rep; 2007 Nov 05; 18(5):1213-7. PubMed ID: 17914575
    [Abstract] [Full Text] [Related]

  • 30. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK.
    Oncogene; 2001 Nov 29; 20(55):8009-18. PubMed ID: 11753684
    [Abstract] [Full Text] [Related]

  • 31. Bowman-Birk protease inhibitor reduces the radiation-induced activation of the EGF receptor and induces tyrosine phosphatase activity.
    Gueven N, Dittmann K, Mayer C, Rodemann HP.
    Int J Radiat Biol; 1998 Feb 29; 73(2):157-62. PubMed ID: 9489562
    [Abstract] [Full Text] [Related]

  • 32. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
    Pantoja C, Serrano M.
    Oncogene; 1999 Sep 02; 18(35):4974-82. PubMed ID: 10490832
    [Abstract] [Full Text] [Related]

  • 33. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J, Le HV, Massagué J.
    Nature; 2002 Oct 17; 419(6908):729-34. PubMed ID: 12384701
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R, Agarwal S, Mathur M, Wasylyk B, Srivastava A.
    Clin Cancer Res; 2000 Jun 17; 6(6):2440-7. PubMed ID: 10873097
    [Abstract] [Full Text] [Related]

  • 36. The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells.
    Dittmann KH, Dikomey E, Mayer C, Rodemann HP.
    Int J Radiat Biol; 2000 Feb 17; 76(2):223-9. PubMed ID: 10716643
    [Abstract] [Full Text] [Related]

  • 37. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
    Yavelow J, Caggana M, Beck KA.
    Cancer Res; 1987 Mar 15; 47(6):1598-601. PubMed ID: 3545448
    [Abstract] [Full Text] [Related]

  • 38. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids.
    Foehr MW, Tomei LD, Goddard JG, Pemberton PA, Bathurst IC.
    Nutr Cancer; 1999 Mar 15; 34(2):199-205. PubMed ID: 10578488
    [Abstract] [Full Text] [Related]

  • 39. The radioprotective potential of the Bowman-Birk protease inhibitor is independent of its secondary structure.
    Gueven N, Dittmann K, Mayer C, Rodemann HP.
    Cancer Lett; 1998 Mar 13; 125(1-2):77-82. PubMed ID: 9566699
    [Abstract] [Full Text] [Related]

  • 40. Identification of a soluble enzyme from C3H/10T1/2 cells which is inhibited by the Bowman-Birk proteinase inhibitor.
    Fagan JM, Waxman L.
    Biochem Biophys Res Commun; 1991 Aug 15; 178(3):856-61. PubMed ID: 1872865
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.